ÂÜÀòÂÒÂ×

Dr Eftychia Lekka is a senior investigator in Drug Discovery at Biovista. Dr Lekka holds a PhD in Cancer Immunology and Immunotherapy (2010), a Master’s degree in Human Molecular Genetics (2003) from Imperial College London, UK and a Bachelor’s degree in Molecular Biology and Genetics (2002) from Royal Holloway, University of London, UK. Prior to joining Biovista, Dr Lekka worked as a research associate at the Cancer Immunology and Immunotherapy Center (CIIC) in Saint Savvas Cancer Hospital, Athens, mainly focusing on the development of peptide vaccine therapeutics for breast and prostate cancer. Furthermore, she has conducted research work in the field of genomic imprinting of fetal growth and development while in the Institute of Reproductive and Developmental Biology (IRDB) in Hammersmith Hospital, London. In addition to her research activities, Dr Lekka has prior expertise in prenatal genetics, particularly in the karyotypic detection of chromosomal abnormalities. Dr Lekka has participated in numerous biomedical conferences, where she has been awarded for her work, and has authored and peer-reviewed publications in international biomedical journals.